MedTrace Logo

Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders

NCT06971692 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2025-05-14

No results posted yet for this study

Summary

The primary goal of this randomized controlled trial is to compare the effectiveness of two transdiagnostic psychological treatments, Metacognitive Therapy (MCT) and the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP), for patients with complex anxiety.

Conditions

  • Posttraumatic Stress Disorder (PTSD)
  • Generalized Anxiety Disorder (GAD)
  • Social Anxiety Disorder (SAD)
  • Panic Disorder (With or Without Agoraphobia)

Interventions

BEHAVIORAL

Metacognitive therapy (MCT)

MCT is delivered in weekly face-to-face sessions

BEHAVIORAL

Unified protocol (UP)

UP is delivered in weekly face-to-face sessions

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06971692 on ClinicalTrials.gov